Allianz Asset Management Gmb H Sarepta Therapeutics, Inc. Transaction History
Allianz Asset Management Gmb H
- $74.9 Billion
- Q2 2025
A detailed history of Allianz Asset Management Gmb H transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 14,760 shares of SRPT stock, worth $344,498. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,760
Previous 40,421
63.48%
Holding current value
$344,498
Previous $2.58 Million
90.23%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding SRPT
# of Institutions
455Shares Held
82.4MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$241 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$214 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$110 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$105 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$59.1 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $2.04B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...